View in EDS

Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?

Saved in:
Bibliographic Details
Title: Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
Authors: Tarantino, P.1,2,3,4 (AUTHOR), Burstein, H.J.3,4 (AUTHOR), Lin, N.U.3,4 (AUTHOR), Krop, I.E.3,4 (AUTHOR), Winer, E.P.3,4 (AUTHOR), Schnitt, S.J.3,4,5 (AUTHOR), Hamilton, E.P.6 (AUTHOR), Hurvitz, S.A.7 (AUTHOR), Rugo, H.S.8 (AUTHOR), Curigliano, G.1,2 (AUTHOR), Tolaney, S.M.3,4 (AUTHOR) Sara_Tolaney@dfci.harvard.edu
Source: Annals of Oncology. Mar2022, Vol. 33 Issue 3, p234-238. 5p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 155152778
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tarantino%2C+P%2E%22">Tarantino, P.</searchLink><relatesTo>1,2,3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burstein%2C+H%2EJ%2E%22">Burstein, H.J.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+N%2EU%2E%22">Lin, N.U.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krop%2C+I%2EE%2E%22">Krop, I.E.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Winer%2C+E%2EP%2E%22">Winer, E.P.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schnitt%2C+S%2EJ%2E%22">Schnitt, S.J.</searchLink><relatesTo>3,4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hamilton%2C+E%2EP%2E%22">Hamilton, E.P.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hurvitz%2C+S%2EA%2E%22">Hurvitz, S.A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rugo%2C+H%2ES%2E%22">Rugo, H.S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curigliano%2C+G%2E%22">Curigliano, G.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tolaney%2C+S%2EM%2E%22">Tolaney, S.M.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> Sara_Tolaney@dfci.harvard.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Mar2022, Vol. 33 Issue 3, p234-238. 5p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=155152778
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.12.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 234
    Titles:
      – TitleFull: Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tarantino, P.
      – PersonEntity:
          Name:
            NameFull: Burstein, H.J.
      – PersonEntity:
          Name:
            NameFull: Lin, N.U.
      – PersonEntity:
          Name:
            NameFull: Krop, I.E.
      – PersonEntity:
          Name:
            NameFull: Winer, E.P.
      – PersonEntity:
          Name:
            NameFull: Schnitt, S.J.
      – PersonEntity:
          Name:
            NameFull: Hamilton, E.P.
      – PersonEntity:
          Name:
            NameFull: Hurvitz, S.A.
      – PersonEntity:
          Name:
            NameFull: Rugo, H.S.
      – PersonEntity:
          Name:
            NameFull: Curigliano, G.
      – PersonEntity:
          Name:
            NameFull: Tolaney, S.M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1